Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP427563.RAnftvgJKb-LtYY_GJmw7CZrjvL0j-phOnu5B7kIhFdFg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP427563.RAnftvgJKb-LtYY_GJmw7CZrjvL0j-phOnu5B7kIhFdFg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP427563.RAnftvgJKb-LtYY_GJmw7CZrjvL0j-phOnu5B7kIhFdFg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP427563.RAnftvgJKb-LtYY_GJmw7CZrjvL0j-phOnu5B7kIhFdFg130_provenance.
- NP427563.RAnftvgJKb-LtYY_GJmw7CZrjvL0j-phOnu5B7kIhFdFg130_assertion description "[Currently prostate-specific membrane antigen (PSMA) is showing promise both as an imaging and therapeutic target for occult prostate cancer metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427563.RAnftvgJKb-LtYY_GJmw7CZrjvL0j-phOnu5B7kIhFdFg130_provenance.
- NP427563.RAnftvgJKb-LtYY_GJmw7CZrjvL0j-phOnu5B7kIhFdFg130_assertion evidence source_evidence_literature NP427563.RAnftvgJKb-LtYY_GJmw7CZrjvL0j-phOnu5B7kIhFdFg130_provenance.
- NP427563.RAnftvgJKb-LtYY_GJmw7CZrjvL0j-phOnu5B7kIhFdFg130_assertion SIO_000772 14716746 NP427563.RAnftvgJKb-LtYY_GJmw7CZrjvL0j-phOnu5B7kIhFdFg130_provenance.
- NP427563.RAnftvgJKb-LtYY_GJmw7CZrjvL0j-phOnu5B7kIhFdFg130_assertion wasDerivedFrom befree-2016 NP427563.RAnftvgJKb-LtYY_GJmw7CZrjvL0j-phOnu5B7kIhFdFg130_provenance.
- NP427563.RAnftvgJKb-LtYY_GJmw7CZrjvL0j-phOnu5B7kIhFdFg130_assertion wasGeneratedBy ECO_0000203 NP427563.RAnftvgJKb-LtYY_GJmw7CZrjvL0j-phOnu5B7kIhFdFg130_provenance.
- befree-2016 importedOn "2016-02-19" NP427563.RAnftvgJKb-LtYY_GJmw7CZrjvL0j-phOnu5B7kIhFdFg130_provenance.